Cardinal Health (NYSE:CAH) Stock Price Target Raised at Royal Bank Of Canada

Cardinal Health (NYSE:CAH) had its target price increased by equities researchers at Royal Bank Of Canada from $276.00 to $295.00 in a research report issued on Friday, Benzinga reports. The firm currently has an “outperform” rating on the stock. Royal Bank Of Canada‘s target price points to a potential upside of 8.57% from the company’s previous close.

CAH has been the topic of several other research reports. Evercore reaffirmed an “outperform” rating and set a $270.00 target price on shares of Cardinal Health in a research note on Wednesday, August 12th. JPMorgan Chase & Co. raised their price target on shares of Cardinal Health from $215.00 to $260.00 and gave the stock a “neutral” rating in a research note on Thursday, August 13th. Wells Fargo & Company boosted their price target on shares of Cardinal Health from $245.00 to $277.00 and gave the stock an “overweight” rating in a research report on Wednesday, August 12th. Barclays upped their price objective on shares of Cardinal Health from $258.00 to $275.00 and gave the company an “overweight” rating in a research note on Thursday, August 13th. Finally, Wall Street Zen upgraded shares of Cardinal Health from a “buy” rating to a “strong-buy” rating in a report on Sunday, October 25th. Sixteen investment analysts have rated the stock with a Buy rating and three have issued a Hold rating to the stock. According to MarketBeat, Cardinal Health has an average rating of “Moderate Buy” and a consensus target price of $272.50.

Cardinal Health Stock Performance

CAH stock traded up $3.88 during trading on Friday, reaching $271.70. The company had a trading volume of 626,651 shares, compared to its average volume of 1,953,749. The company has a market cap of $62.92 billion, a price-to-earnings ratio of 37.59, a price-to-earnings-growth ratio of 1.57 and a beta of 0.53. Cardinal Health has a twelve month low of $180.45 and a twelve month high of $286.29. The firm has a 50-day simple moving average of $239.73 and a 200-day simple moving average of $223.24.

Cardinal Health (NYSE:CAH) last issued its earnings results on Thursday, November 5th. The company reported $3.26 EPS for the quarter, topping analysts’ consensus estimates of $2.94 by $0.32. Cardinal Health had a negative return on equity of 98.53% and a net margin of 0.67%. The firm had revenue of $67.51 billion for the quarter, compared to the consensus estimate of $66.67 billion. During the same quarter in the prior year, the business earned $2.55 earnings per share. The company’s revenue was up 5.5% compared to the same quarter last year. Sell-side analysts expect that Cardinal Health will post 12.55 earnings per share for the current year.

Insider Buying and Selling

In related news, CEO Deborah Weitzman sold 7,354 shares of the company’s stock in a transaction on Tuesday, August 18th. The shares were sold at an average price of $235.45, for a total value of $1,731,499.30. Following the completion of the sale, the chief executive officer owned 77,901 shares in the company, valued at $18,341,790.45. This represents a 8.63% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. Also, CEO Stephen Mason sold 35,000 shares of Cardinal Health stock in a transaction that occurred on Tuesday, August 18th. The shares were sold at an average price of $236.40, for a total value of $8,274,000.00. Following the completion of the transaction, the chief executive officer owned 18,061 shares in the company, valued at $4,269,620.40. This trade represents a 65.96% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. Insiders have sold a total of 210,271 shares of company stock valued at $49,626,657 over the last ninety days. Company insiders own 0.12% of the company’s stock.

Hedge Funds Weigh In On Cardinal Health

Several institutional investors have recently added to or reduced their stakes in CAH. Downshift Financial LLC boosted its position in shares of Cardinal Health by 3,666.7% in the 3rd quarter. Downshift Financial LLC now owns 113 shares of the company’s stock worth $25,000 after buying an additional 110 shares in the last quarter. Maryland Capital Advisors Inc. increased its position in shares of Cardinal Health by 12,600.0% in the third quarter. Maryland Capital Advisors Inc. now owns 127 shares of the company’s stock worth $28,000 after acquiring an additional 126 shares in the last quarter. Investors Research Corp acquired a new stake in shares of Cardinal Health in the second quarter valued at about $29,000. Allied Private Wealth LLC acquired a new position in shares of Cardinal Health during the second quarter worth $30,000. Finally, Brown Lisle Cummings Inc. grew its stake in shares of Cardinal Health by 1,562.5% during the third quarter. Brown Lisle Cummings Inc. now owns 133 shares of the company’s stock valued at $30,000 after acquiring an additional 125 shares in the last quarter. 87.17% of the stock is currently owned by institutional investors and hedge funds.

Key Headlines Impacting Cardinal Health

Here are the key news stories impacting Cardinal Health this week:

• Positive Sentiment: Adjusted EPS was $3.26, ahead of analyst expectations of about $2.94, while revenue rose 5% year over year to $67.5 billion and also beat forecasts. Read More.
• Positive Sentiment: Cardinal raised its fiscal 2027 adjusted EPS outlook to $12.80–$13.00, above the FactSet estimate of $12.57. Management cited specialty growth, strong generics demand and customer renewals as support for the outlook. Read More.
• Positive Sentiment: The company completed a $500 million share-repurchase program during the quarter, adding a capital-return tailwind. Read More.
• Neutral Sentiment: Medical distribution faced modest commodity and petroleum-related cost pressure. Strong pharmaceutical sales helped offset the headwinds, but they remain a factor for investors to monitor. Read More.

About Cardinal Health

Cardinal Health, Inc is a healthcare services and products company that supports the distribution and delivery of pharmaceuticals, medical products and related services. The company serves hospitals, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices and other healthcare providers.

Its Pharmaceutical and Specialty Solutions segment distributes branded, generic and specialty pharmaceuticals, as well as consumer health products, to pharmacies and healthcare institutions.